In the broad healthcare landscape, one area that has historically been overlooked and under-prioritized is women's health.

Clerkenwell Health is proud to announce the launch of its foundation course for Psychedelic-Assisted Therapy, a comprehensive ...

Owlstone Medical, a global leader in Breath Biopsy for early disease detection and precision medicine, has announced a ...

Interview: Is global AI regulation really revolutionizing pharma and clinical trials?

Lonza, a global partner in the pharmaceutical, biotech, and nutraceutical sectors, announced the introduction of its ...

A significant milestone has been reached by Olden Labs as it steps into the limelight revealing its refreshing approach to ...

OSP spoke to Berkeley Research Group healthcare managing director, Wendy Cheng for a discussion around developments in AI ...

Response Pharmaceuticals, Inc., has unveiled significant findings from its Phase 1b clinical trial of RDX-002, signaling a ...

In an extensive and enlightening chat with Prasad Rajeev, the CEO of LGM Pharma, OSP gained profound insights into the ...

A recent Deloitte report revealed that 36% of healthcare product launches fell short of achieving 80% of their sales targets ...

OSP was excited to write about One2Treat, a progressive startup specializing in digital health solutions, which has launched ...

Wuxi AppTec says recent allegations made by the US government that it has shared clients' data with Beijing without consent ...